Search for Novel Remedies to Augment Radiation Resistance of Inhabitants of Fukushima and Chernobyl Disasters: Identifying DNA Repair Protein XRCC4 Inhibitors-Reference-Cited by-同舟云学术

Search for Novel Remedies to Augment Radiation Resistance of Inhabitants of Fukushima and Chernobyl Disasters: Identifying DNA Repair Protein XRCC4 Inhibitors

Published:2011-10 Issue:2 Volume:29 Page:325-337
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Sun Mao-Feng,Chen Hsin-Yi,Tsai Fuu-Jen,Liu Shu-Hui,Chen Chih-Yi,Chen Calvin Yu-Chian

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference37 articles.

1. Chromosomal stability and the DNA double-stranded break connection

2. Coordinated Assembly of Ku and p460 Subunits of the DNA-dependent Protein Kinase on DNA Ends is Necessary for XRCC4–ligase IV Recruitment

3. XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps

4. Structural and Functional Interaction between the Human DNA Repair Proteins DNA Ligase IV and XRCC4

5. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIF1α Contribution to the NHEJ DNA Repair Pathway Through Decreased Expression of XRCC4;Jentashapir Journal of Cellular and Molecular Biology;2024-02-18

2. Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair;Frontiers in Oncology;2022-04-06

3. The diagnostic value of DNA repair gene in breast cancer metastasis;Scientific Reports;2020-11-12

4. Druggable binding sites in the multicomponent assemblies that characterise DNA double-strand-break repair through non-homologous end joining;Essays in Biochemistry;2020-06-24

5. PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma;Biochemical and Biophysical Research Communications;2020-01